Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Kidney Research and Clinical Practice is Scopus-indexed (Q1, CiteScore 5.9), WoS SCIE, DOAJ. Published by The Korean Society of Nephrology.
Checked against the index lists dated .
ISSN 2211-9132Verify ISSN ↗2211-9140Verify ISSN ↗
Publisher: The Korean Society of Nephrology
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Urology | 17 / 123 | 86th | Q1 |
| Nephrology | 16 / 88 | 82nd | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 5.9.
Kidney Research and Clinical Practice is Q1 in Urology (rank 17 of 123) and Q1 in Nephrology (rank 16 of 88), by CiteScore 2025.
Kidney Research and Clinical Practice is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.9, which places it in quartile Q1 at the 86th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.071, quartile Q1, with an H-index of 41.
Kidney Research and Clinical Practice is published by The Korean Society of Nephrology. Its print ISSN is 2211-9132 and its online ISSN is 2211-9140.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Kidney Research and Clinical Practice has an h-index of 48 and a 2-year mean of 2.1 citations per paper (OpenAlex). Its Scopus CiteScore is 5.9, quartile Q1. On 2-year citations it ranks #34 of 123 Scopus journals in Urology.
Kidney Research and Clinical Practice published 129 papers in 2025; its busiest recent year was 2024 with 135. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from South Korea (66.3%), China (12%) and United States (4.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.